Assertio Holdings’ latest analyst update keeps the price target steady at $37.44, signaling no change in the headline valuation anchor. Bullish voices see this reaffirmed target as consistent with ...

Here is how Assertio (ASRT) and Aura Biosciences, Inc. (AURA) have performed compared to their sector so far this year.

Below is Validea's guru fundamental report for ASSERTIO HOLDINGS INC (ASRT). Of the 22 guru strategies we follow, ASRT rates highest using our Acquirer's Multiple Investor model based on the published ...

Shares of Assertio (NASDAQ:ASRT) closed 8% higher Monday after the company refuted allegations leveled by activist investor Buxton Helmsley over its accounting practices and approval of its drug ...

$ASRT insiders have traded $ASRT stock on the open market 2 times in the past 6 months. Of those trades, 2 have been purchases and 0 have been sales. Here’s a ...

In Q1 FY2023, Assertio achieved significant progress in executing the new strategy brought on board by CEO Dan Peisert. The market expects ASRT's EPS to decline nearly 82% YoY in FY2023, but then ...